Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 574 of 6351
-
Could a common antidepressant boost cancer immunotherapy?
Disease control Recruiting nowAdvanced liver and gallbladder malignancies (including liver cancer, cholangiocarcinoma and gallbladder cancer) are a type of disease that is difficult to treat, and most patients have a short survival period. In recent years, immunotherapy (such as PD-1/PD-L1 inhibitors) has bro…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for lung cancer patients with brain tumors: drug duo enters trial
Disease control Not yet recruitingThis is a prospective, single-center, phase 2 clinical study to explore the efficacy and safety of Sac-TMT in combination with bevacizumab for patients with EGFR-mutated nonsquamous NSCLC with brain metastases. The study will enroll 50 EGFR-sensitive mutation(19del/21L858R) nonsq…
Phase 2 • Sponsor: Li-kun Chen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug aims to save kidneys: 3,000-Patient trial launches
Disease control Not yet recruitingChronic kidney disease CKD is estimated to affect nearly over 800 million people globally today (with roughly 125,000 people ending up annually on dialysis in the United States alone. CKD is a contributor to illness and is associated with a diminished quality of life and reduced …
Phase 2/3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 26, 2026 14:50 UTC
-
New hope for advanced cervical cancer: Triple-Drug combo trial launches
Disease control Not yet recruitingThis is a multicenter, randomized, open-label Phase II/III clinical study, aiming to evaluate the efficacy and safety of LB1410 in combination with lenvatinib (whether in combination with LB4330)versus the chemotherapy regimen selected by the investigators for patients with advan…
Phase 2/3 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Jun 26, 2026 17:31 UTC
-
Gene-Tailored drugs aim to tackle tough bile duct cancer
Disease control Not yet recruitingThis is a multi-center, real-world study aiming to evaluate the efficacy and safety of precision treatment for advanced cholangiocarcinoma (CCA) with different molecular subtypes.
Sponsor: Mao-Lin Yan • Aim: Disease control
Last updated Jun 26, 2026 15:27 UTC
-
Brain zaps and VR worlds: a new hope for early Alzheimer's?
Disease control Not yet recruitingAs populations age, Alzheimer's disease (AD) is increasing while disease-modifying drugs remain elusive, making early diagnosis and intervention essential. Building on advances in neuromodulation and virtual reality (VR), we target amnestic mild cognitive impairment (aMCI)-the pr…
Sponsor: Yuan Shen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Simple nasal spray may prevent hearing loss in cancer survivors
Prevention Not yet recruitingThis study focuses on a common side effect experienced by many patients after radiation therapy for nasopharyngeal cancer, which is a type of head and neck cancer. This side effect is called secretory otitis media (fluid buildup in the middle ear). It can cause a feeling of fulln…
Phase 3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Cord blood stem cells aim to restore movement in stroke survivors
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy, safety, and pharmacodynamic characteristics of Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) in adults with ischemic stroke in the anterior circulation during the recovery phase. Researchers will compare hUC-MS…
Phase 2 • Sponsor: Shanghai IxCell Biotechnology Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis is a Phase II, single-arm, open-label, multicenter clinical study aimed at evaluating the efficacy and safety of Firmonertinib 160 mg combined with Bevacizumab as neoadjuvant therapy in patients with resectable stage II-IIIB Epidermal Growth Factor Receptor(EGFR)-mutated non…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 26, 2026 19:13 UTC
-
Radiation before surgery: a new hope for tough breast cancers?
Disease control Not yet recruitingApproximately 20% of breast cancer patients in our country are in the locally advanced stage. The relatively low overall survival rate, high recurrence rate and distant metastasis risk of these patients significantly affect the therapeutic efficacy and survival. Preoperative radi…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 16:14 UTC
-
Umbilical cord stem cells injected into legs to fight diabetic nerve pain
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of human umbilical cord mesenchymal stem cell (hUC-MSC) injection in the treatment of adults with moderate to severe diabetic peripheral neuropathy. Researchers will compare hUC-MSCs injection combined with conventiona…
Phase 2 • Sponsor: Min Long • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on autoimmune diseases in early trial
Disease control Recruiting nowThis study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-CD19-GDT in relapsed/refractory autoimmune diseases.
Phase 1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:33 UTC
-
New combo therapy shows promise for tough breast cancer
Disease control Recruiting nowThis document outlines an investigator-initiated Phase Ib/II clinical trial in Japan, focusing on the combination therapy of ribociclib and anastrozole for patients with hormone receptor-positive (HR-positive), HER2-negative metastatic or recurrent breast cancer. The trial aims t…
Phase 1/2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common steroid boost stroke recovery?
Disease control Not yet recruitingIt is uncertain whether intravenous methylprednisolone improves outcomes for acute anterior circulation large vessel occlusion (LVO) patients with a large infarct core. In this study, the investigators hypothesize that methylprednisolone plus endovascular thrombectomy (EVT) might…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 26, 2026 18:28 UTC
-
Tiny radiation seeds take aim at deadly brain tumors
Disease control Recruiting nowA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of recurrent Glioblastoma
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Rectal cancer breakthrough: could chemo replace surgery for some patients?
Disease control Recruiting nowThis study investigates the feasibility of an organ-preserving "watch-and-wait" strategy in patients with mid-to-low rectal cancer who achieve a good response after total neoadjuvant therapy (TNT). By retrospectively and prospectively analyzing patients who complete TNT following…
Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo therapy aims to wipe out lymphoma without prior treatment
Disease control OngoingIn patients with previously untreated Marginal zone lymphoma (MZL), a treatment regimen of Orelabrutinib,Zuberitamab combined with Cyclophosphamide,Vincristine,Prednisoneacetatetablets is planned to be used.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can early rhythm control stop hidden heart rhythms from becoming dangerous?
Disease control Recruiting nowAtrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs) are associated with an increased risk of progression to clinical atrial fibrillation (AF), stroke, heart failure, and mortality. However, optimal management strategies for patients with A…
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Wrist-Worn sensor outsmart atrial fibrillation?
Diagnosis Recruiting nowThis is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-process…
Sponsor: Seerlinq s. r. o. • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Can a light cap predict stroke in sickle cell disease?
Knowledge-focused Recruiting nowThe purpose of the study protocol is to identify imaging biomarkers for brain tissue under high metabolic stress at risk for permanent injury. We will measure oxygen extraction fraction (OEF) and cerebrovascular reactivity (CVR) in participants with and without perturbations in c…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC